|
|
||||||||
J Neurophysiol (March 1, 2003). 10.1152/jn.00908.2002
Submitted on Submitted 25 March 2002; accepted in final form 31 October 2002
Department of Physiology and Biophysics, University of Alabama at Birmingham, Birmingham, Alabama 35294
| |
ABSTRACT |
|---|
|
|
|---|
Chattipakorn, Siriporn C. and
Lori L. McMahon.
Strychnine-Sensitive Glycine Receptors Depress Hyperexcitability
in Rat Dentate Gyrus.
J. Neurophysiol. 89: 1339-1342, 2003.
Previously we have shown that
strychnine-sensitive glycine-gated chloride channels (GlyRs) are
functionally expressed by CA1 pyramidal cells and GABAergic
interneurons in mature rat hippocampal slices. We now report that
glycine application to dentate granule cells and hilar interneurons
recorded in acute slices from adolescent rats elicits a
strychnine-sensitive current similar to glycine-mediated currents
recorded in area CA1, indicating that GlyRs are also present on neurons
in the dentate gyrus. This finding suggests that GlyRs have a
widespread distribution in the hippocampal region. The physiological
role of GlyRs in forebrain is unclear, but it is possible that these
receptors mediate neuronal inhibition, similar to
-aminobutyric
acid-A (GABAA) receptors and thus could be a
novel target for antiepileptic therapy. Therefore we tested the
hypothesis that activation of inhibitory GlyRs could suppress neuronal
hyperexcitability in dentate, a brain region vulnerable to epileptic
activity. In whole-cell current-clamp recordings of granule cells, we
observed a membrane potential hyperpolarization followed by cessation
of the action potential firing pattern in hyperexcitable slices induced
by elevated extracellular K+ or by blocking
GABAA receptors with bicuculline. The GlyR
antagonist, strychnine, prevented the antiepileptic effect of glycine.
These results demonstrate that glycine, acting at GlyRs, elicits
neuronal inhibition in dentate. Further, our findings suggest the
possibility that these receptors could be a therapeutic target for the
treatment of epilepsy.
| |
INTRODUCTION |
|---|
|
|
|---|
The dentate gyrus (DG)
is a brain region highly susceptible to seizure activity (Parent
and Lowenstein 2002
; Scharfman 2000
). Several
lines of evidence suggest that loss of GABA-mediated inhibition in DG
plays a role in the pathophysiology and pathology of epilepsy (Coulter 2000
; Dalby and Mody 2001
;
Dudek et al. 2002
; Sloviter 1996
). Thus
the availability of additional or alternate inhibitory mechanisms would
be useful since effective neuronal inhibition is required to maintain
the normal excitatory balance for proper function of DG as well as
other regions throughout the forebrain. Glycine-gated chloride channels
(GlyRs) could subserve this role. In fact, accumulating evidence shows
that strychnine-sensitive GlyRs are functionally expressed in many
regions of developing and mature brain (Sergeeva and Haas
2001
; Ye 2000
), including hippocampus
(Mori et al. 2002
; Sergeeva and Haas
2001
; Ye 2000
; Ye et al. 1999
;
Yoon et al. 1998
), where we have previously
characterized the pharmacological properties of GlyRs expressed by CA1
pyramidal cells and GABAergic interneurons recorded in hippocampal
slices (Chattipakorn and McMahon 2002
). Interestingly,
previous work in vivo has demonstrated that exogenous glycine
application can depress seizure activity in an animal model of epilepsy
(Cherubini et al. 1981
) and can potentiate the
antiepileptic effects of
-aminobutyric acid-A receptor
(GABAAR) agonists (Seiler and Sarhan
1984a
,b
). Therefore activation of GlyRs either alone or in
combination with GABAARs may provide an
alternative therapeutic approach for the better treatment of epilepsy.
An inhibitory role of glycine acting at GlyRs in DG has not been examined previously despite the possibility that these receptors may provide an important inhibitory mechanism in this highly excitable brain region. Therefore in the present study, we used patch-clamp electrophysiology to provide evidence that both granule cells and hilar interneurons express functional GlyRs. Furthermore, we investigated whether GlyR activation can inhibit bursting activity elicited in DG slices. Our findings indicate that GlyRs are expressed by neurons in DG and their activation provides an inhibitory mechanism that has been overlooked previously.
| |
METHODS |
|---|
|
|
|---|
Electrophysiological recordings
Coronal hippocampal slices (400 µM) were prepared from 3- to
4-wk-old Sprague-Dawley rats using a high-sucrose, low-calcium artificial cerebrospinal fluid (ACSF) solution containing the following
(in mM): 85 NaCl; 2.5 KCl; 0.5 CaCl2; 4 Mg2SO4; 1.25 NaH2PO4; 25 NaHCO3; 25 glucose; 2 kynurenic acid; 0.5 ascorbate and saturated with 95% O2-5%
CO2 (pH 7.4). Slices were maintained in a
submersion chamber at room temperature in the high-sucrose solution for
30 min before switching to a standard ACSF solution containing the
following (in mM): 119 NaCl; 2.5 KCl; 2.5 CaCl2; 1.3 MgSO4; 1 NaH2PO4; 26 NaHCO3; 10 glucose; 2 kynurenic acid and
saturated with 95% O2-5%
CO2 (pH 7.4). For experiments, slices were placed
in a submersion recording chamber and continually perfused with ACSF
containing 2 mM kynurenic acid (voltage-clamp experiments only) at 2-3
ml/min and warmed to 28-30°C. Whole-cell voltage and current-clamp
recordings of visually identified granule cells and hilar interneurons
were obtained using infrared differential interference contrast
microscopy and standard recording techniques as previously described
(Chattipakorn and McMahon 2002
). The interneurons recorded in this study were limited to those cells located at the
border between the granule cell layer and the hilus (Ribak and
Seress 1983
). Patch electrodes had resistances between 4 and 6 M
and for voltage-clamp recordings were filled with the following (in mM): 100 CsCl; 0.6 EGTA; 5 MgCl2; 2 ATP-Na2; 3 GTP-Na; 40 HEPES; and biocytin 0.4%,
pH 7.2, 260-270 mOsm. In some recordings, 5 mM QX 314 was added to the
internal solution to block voltage-dependent Na+
channels. Series resistance was continuously monitored throughout the
experiments and recordings were terminated when there was a >20%
change. For current-clamp recordings of granule cells, 100 mM
K+ gluconate was substituted for CsCl. These
granule cells had an average input resistance of 373 ± 30 M
and resting membrane potential of 69 ± 1 mV (n = 21). Recordings were terminated if there was a >20% change in these
parameters and if action potential amplitude was not overshooting. All
slices were fixed in 4% paraformaldehyde following experiments and
processed for biocytin staining of recorded neurons to confirm cell
identity as a granule cell or hilar interneuron. Filled cells were
visualized at the light level and images were reconstructed using
camera lucida. Representative cells are shown in Fig.
1B. Our visual identification
of recorded cells using IR-DIC optics consistently matched the identity
obtained with the biocytin fill.
|
Drug delivery
All chemicals used in this study were purchased from
Sigma-Aldrich Co. (St. Louis, MO). Agonists and antagonists were
prepared as stock solutions and diluted to appropriate concentrations
in the recording solution. To test for the functional expression of
GlyRs by granule cells and hilar interneurons, glycine (300 µM) was
applied by pressure ejection (3-6 s) using a picospritzer with the
drug-containing pipette positioned 50-100 µm from the recorded cell.
The method of glycine application for obtaining dose-response
measurements was performed using a drug pipette connected to a valve
system which permits switching between drug solutions (4-5 ml/min;
complete bath exchange within 30 s) as previously described
(Chattipakorn and McMahon 2002
). Dose-response data were
normalized to the amplitude measured at 1 mM glycine and were fit to
the Hill equation I = Imax/1 + (EC50/[agonist]n) using
Origin 5.0 software (Chattipakorn and McMahon 2002
). To test whether GlyR activation could depress neuronal hyperexcitability, glycine (300 µM) was applied to granule cells recorded in whole-cell current clamp while perfusing the slices with high extracellular K+ (8.5 mM) or 10 µM bicuculline to block
GABAA receptor-mediated inhibition.
| |
RESULTS |
|---|
|
|
|---|
Glycine currents recorded in rat dentate gyrus
To demonstrate that dentate neurons have functional GlyRs, we
obtained whole-cell recordings of visually identified granule cells and
hilar cells in slices prepared from 3- to 4-wk-old animals. Short
pulses (3 s) of glycine (300 µM) pressure-applied to both granule
cells (n = 11/11) and hilar cells (n = 15/15) elicited inward currents (Igly;
ECl
= 0 mV) that rapidly decayed to baseline
following cessation of glycine application (Fig. 1A). Bath
application of the GABAA antagonist, bicuculline
(10 µM; n = 10), had no effect on
Igly. In contrast, bath application of
strychnine (1 µM; n = 10) reversibly depressed or
abolished Igly, reaching maximal block
within 8-10 min. A partial recovery was obtained following washout of
the antagonist (20-30 min). The mean
Igly elicited by 300 µM glycine
(near EC50 concentration) recorded from granule
cells (500-1,500 pA, 916 ± 162 pA) and hilar cells (350-3,000
pA, 1,050 ± 345 pA) were not significantly different (P = 0.73). To confirm cell identity, recorded
cells were filled with biocytin for post hoc analysis. Figure
1B shows camera lucida reconstructions of a typically
recorded granule cell and hilar interneuron that responded to glycine
with a strychnine-sensitive inward current.
To further characterize the sensitivity of GlyRs to glycine, we
generated dose-response curves from both cell types (Fig. 2). Normalized dose-response
relationships demonstrate that GlyRs expressed by granule cells
(EC50 = 360 µM and Hill coefficient n = 1.2) and hilar cells (EC50 = 370 µM and Hill coefficient n = 1.6) respond
similarly to glycine (Fig. 2B). Additionally, we observed
that Igly recorded from both cell
types only partially desensitize during the 1-min exposure to glycine
(concentrations
1 mM, Fig. 2A) and reach a steady-state
level. This is an important issue since the cerebrospinal fluid (CSF)
glycine concentration can be elevated for prolonged periods following
seizures and hypoxic episodes (Andine et al. 1991
;
Castillo et al. 1996
; Sherwin 1999
). Our
data suggest therefore that under these pathological conditions, GlyR-mediated inhibition will remain functional, although at a reduced
level.
|
GlyR activation inhibits neuronal hyperexcitability
To test the antiepileptic potential of GlyR activation, glycine
was applied to hyperexcitable dentate slices. Hyperexcitability was
induced either by increasing extracellular
[K+]o (8.5 mM), which elicits spontaneous
discharges in granule cells resembling epileptic spikes
(Chamberlin et al. 1990
) (n = 6), or by
blocking GABAA-mediated inhibition with 10 µM
bicuculline (n = 6). GABAAR blockade alone does not elicit spontaneous discharges; therefore, we
applied depolarizing current (usually 5-6 mV) to bring cells to action
potential threshold. In the majority of granule cell recordings
(n = 8/12) bath application of 300 µM glycine
hyperpolarized the membrane potential (8 ± 2 mV in 8.5 mM
[K+]o and 9 ± 2 mV
in bicuculline) and completely interrupted the hyperexcitable firing
pattern (Fig. 3). In the remaining four cells (2 recorded in 8.5 mM K+ and 2 in bicuculline) action potential firing was considerably depressed (26 ± 6% of control; 120 ± 6 spikes/min in control vs. 33 ± 6 spikes/min in glycine)
(data not shown). The decrementing action potential amplitude observed in some of our experiments has been previously reported by others (Pan and Stringer 1996
; Schweitzer et al.
1992
) and is not related to deterioration of cell health, since
no changes were observed in membrane input resistance or membrane
potential. Thus this effect is likely a result of decreased ionic
driving force resulting from the prolonged high rate of action
potential firing that is occurring over tens of minutes to an hour.
Co-application of strychnine (1 µM) and glycine prevented the
antiepileptic effect of glycine without changing the firing rate
(n = 4). These data suggest that the anti-bursting
activity of glycine was mediated through the activation of GlyRs.
Furthermore, the ability of GlyR activation to depress action potential
generation in the presence of GABAAR blockade
demonstrates that GlyRs can provide effective inhibition when GABAergic
inhibition is compromised.
|
| |
DISCUSSION |
|---|
|
|
|---|
This study represents the first report of strychnine-sensitive
glycine currents recorded from granule cells and hilar interneurons, indicating the expression of glycine-gated chloride channels (GlyRs) in
the dentate gyrus. In addition, our data show clearly that glycine, via
GlyR activation, depresses granule cell bursting activity under
hyperexcitable conditions, even when GABAAR
inhibition is compromised. These findings imply that GlyR-mediated
inhibition is an alternative or additional inhibitory mechanism to the
familiar GABAAR-mediated mechanism and that GlyR
activation is capable of controlling the activity of excitatory
circuits in DG. Furthermore, these data suggest the strong possibility
that GlyRs could be an important target for antiepileptic therapy.
Surprisingly, these receptors have not received strong consideration
previously despite the fact that a few studies have shown glycine to be
antiepileptic in some animal models of epilepsy (Cherubini et
al. 1981
; Seiler and Sarhan 1984a
) and to
potentiate the antiepileptic effect of GABAAR
agonists (Seiler and Sarhan 1984a
). Therefore we propose that activation of GlyRs alone or in combination with
GABAA receptors may provide an alternative
therapeutic approach for the better treatment of epilepsy.
Our finding that both principal cells and interneurons in DG express
GlyRs, consistent with our studies in the CA1 region (Chattipakorn and McMahon 2002
), indicates that these
receptors are likely of fundamental importance in the control of
neuronal excitability in this region. Because both excitatory and
inhibitory neurons respond to glycine, the effect of GlyR activation on
dentate circuitry will entirely depend on when the receptors are
activated and on what cell type. For example, if these receptors are
selectively activated on granule cells, the output of the dentate will
be decreased. However, selective activation of GlyRs on interneurons could cause disinhibition of the granule cells, thereby increasing the
output of the dentate. The source of glycine and other GlyR agonists
(taurine) (Mori et al. 2002
) in forebrain, including dentate, is not presently known. However, synaptosomes prepared from
hippocampus release glycine via both
Ca2+-dependent and independent mechanisms
(Engblom et al. 1996
), suggesting both vesicular and
transporter-mediated release. Knowledge of the specific source of GlyR
agonists and under what conditions these agonists are released will
shed light on the role of these receptors in controlling dentate circuitry.
Since our study was performed in acutely prepared slices from 3- to 4-wk-old rats, our data demonstrate that GlyR expression by dentate neurons is not transient and limited to early development but persists through mature developmental stages. The glycine-induced inhibition of action potential firing occurs in the absence of N-methyl-D-aspartate receptor (NMDAR) blockade, suggesting that increases in the CSF glycine concentration, particularly when excitability is high, can elicit neuronal inhibition, thus overcoming any potential increase in glycine-mediated NMDAR-induced excitability.
The physiological role of GlyRs in the hippocampal formation is
currently unknown and whether these receptors mediate fast synaptic
inhibition as they do in spinal cord and brain stem has yet to be
documented. In cerebellum, GlyRs are involved in synaptic inhibition
following the vesicular release of glycine, while in cortex GlyRs
appear to be activated by nonsynaptically released taurine
(Flint et al. 1998
), suggesting an extrasynaptic
location of GlyRs. To increase our understanding of these understudied receptors in hippocampus, future investigations are needed to determine
the synaptic versus extrasynaptic location of GlyRs and the conditions
under which these receptors are activated.
| |
ACKNOWLEDGMENTS |
|---|
We thank Dr. Virginia Wotring for helpful comments on the manuscript and C. Starr for secretarial assistance.
This work was supported by an Epilepsy Foundation postdoctoral fellowship to S. C. Chattipakorn, and the American Heart Association and National Institute of Neurological Disorders and Stroke Grant NS-41382 to L. L. McMahon.
| |
FOOTNOTES |
|---|
Address for reprint requests: L. L. McMahon, Department of Physiology and Biophysics, 1918 University Blvd., MCLM 964, University of Alabama at Birmingham, Birmingham, AL 35294-0005 (E-mail: McMahon{at}physiology.uab.edu).
| |
REFERENCES |
|---|
|
|
|---|
This article has been cited by other articles:
![]() |
X.-B. Zhang, G.-C. Sun, L.-Y. Liu, F. Yu, and T.-L. Xu {alpha}2 Subunit Specificity of Cyclothiazide Inhibition on Glycine Receptors Mol. Pharmacol., April 1, 2008; 73(4): 1195 - 1202. [Abstract] [Full Text] [PDF] |
||||
![]() |
H. X. Zhang and L. L. Thio Zinc Enhances the Inhibitory Effects of Strychnine-Sensitive Glycine Receptors in Mouse Hippocampal Neurons J Neurophysiol, December 1, 2007; 98(6): 3666 - 3676. [Abstract] [Full Text] [PDF] |
||||
![]() |
W. Song, S. C. Chattipakorn, and L. L. McMahon Glycine-Gated Chloride Channels Depress Synaptic Transmission in Rat Hippocampus J Neurophysiol, April 1, 2006; 95(4): 2366 - 2379. [Abstract] [Full Text] [PDF] |
||||
![]() |
N. Lozovaya, N. Yatsenko, A. Beketov, T. Tsintsadze, and N. Burnashev Glycine Receptors in CNS Neurons as a Target for Nonretrograde Action of Cannabinoids J. Neurosci., August 17, 2005; 25(33): 7499 - 7506. [Abstract] [Full Text] [PDF] |
||||
![]() |
J.-M. Mangin, L. Nguyen, C. Gougnard, G. Hans, B. Rogister, S. Belachew, G. Moonen, P. Legendre, and J.-M. Rigo Developmental Regulation of {beta}-Carboline-Induced Inhibition of Glycine-Evoked Responses Depends on Glycine Receptor {beta} Subunit Expression Mol. Pharmacol., May 1, 2005; 67(5): 1783 - 1796. [Abstract] [Full Text] [PDF] |
||||
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| HOME | HELP | FEEDBACK | SUBSCRIPTIONS | ARCHIVE | SEARCH | TABLE OF CONTENTS |
| Visit Other APS Journals Online |